Literature DB >> 11801673

Induction of TNF in human alveolar macrophages as a potential evasion mechanism of virulent Mycobacterium tuberculosis.

Matthias Engele1, Elmar Stössel, Kirstin Castiglione, Nives Schwerdtner, Manfred Wagner, Pal Bölcskei, Martin Röllinghoff, Steffen Stenger.   

Abstract

The ability of macrophages to release cytokines is crucial to the host response to intracellular infection. In particular, macrophage-derived TNF plays an important role in the host response to infection with the intracellular pathogen Mycobacterium tuberculosis. In mice, TNF is indispensable for the formation of tuberculous granulomas, which serve to demarcate the virulent bacterium. TNF is also implicated in many of the immunopathological features of tuberculosis. To investigate the role of TNF in the local immune response, we infected human alveolar macrophages with virulent and attenuated mycobacteria. Infection with virulent strains induced the secretion of significantly higher levels of bioactive TNF than attenuated strains correlating with their ability to multiply intracellularly. Treatment of infected macrophages with neutralizing anti-TNF Abs reduced the growth rate of intracellular bacteria, whereas bacterial replication was augmented by addition of exogenous TNF. Infected and uninfected macrophages contributed to cytokine production as determined by double-staining of M. tuberculosis and intracellular TNF. The induction of TNF by human alveolar macrophages at the site of infection permits the multiplication of intracellular bacteria and may therefore present an evasion mechanism of human pathogens.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11801673     DOI: 10.4049/jimmunol.168.3.1328

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  51 in total

1.  Evaluation of the cell growth of mycobacteria using Mycobacterium smegmatis mc2 155 as a representative species.

Authors:  Jorge A Gonzalez-Y-Merchand; Ruben Zaragoza-Contreras; Rosalina Guadarrama-Medina; Addy C Helguera-Repetto; Sandra Rivera-Gutierrez; Jorge F Cerna-Cortes; Leopoldo Santos-Argumedo; Robert A Cox
Journal:  J Microbiol       Date:  2012-06-30       Impact factor: 3.422

2.  Tumor necrosis factor signaling mediates resistance to mycobacteria by inhibiting bacterial growth and macrophage death.

Authors:  Hilary Clay; Hannah E Volkman; Lalita Ramakrishnan
Journal:  Immunity       Date:  2008-08-15       Impact factor: 31.745

3.  Modeling the immune rheostat of macrophages in the lung in response to infection.

Authors:  Judy Day; Avner Friedman; Larry S Schlesinger
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-22       Impact factor: 11.205

Review 4.  Pathogenesis of dermatophytosis.

Authors:  Sandy Vermout; Jérémy Tabart; Aline Baldo; Anne Mathy; Bertrand Losson; Bernard Mignon
Journal:  Mycopathologia       Date:  2008-05-14       Impact factor: 2.574

Review 5.  Immunology of dermatophytosis.

Authors:  Sandro Rogerio Almeida
Journal:  Mycopathologia       Date:  2008-05-14       Impact factor: 2.574

6.  Neutralization of tumor necrosis factor alpha suppresses antigen-specific type 1 cytokine responses and reverses the inhibition of mycobacterial survival in cocultures of immune guinea pig T lymphocytes and infected macrophages.

Authors:  Hyosun Cho; David N McMurray
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

7.  Soluble TNFRp75 regulates host protective immunity against Mycobacterium tuberculosis.

Authors:  Roanne Keeton; Nasiema Allie; Ivy Dambuza; Brian Abel; Nai-Jen Hsu; Boipelo Sebesho; Philippa Randall; Patricia Burger; Elizabeth Fick; Valerie F J Quesniaux; Bernhard Ryffel; Muazzam Jacobs
Journal:  J Clin Invest       Date:  2014-02-24       Impact factor: 14.808

8.  Identification of a new tuberculosis antigen recognized by γδ T cell receptor.

Authors:  Xueyan Xi; Xiqin Han; Liang Li; Zhendong Zhao
Journal:  Clin Vaccine Immunol       Date:  2013-02-06

9.  Molecular characterization of clinical isolates of Mycobacterium tuberculosis and their association with phenotypic virulence in human macrophages.

Authors:  K C Wong; W M Leong; H K W Law; K F Ip; J T H Lam; K Y Yuen; P L Ho; W S Tse; X H Weng; W H Zhang; S Chen; W C Yam
Journal:  Clin Vaccine Immunol       Date:  2007-08-22

10.  Increased risk of tuberculosis in patients treated with antitumor necrosis factor alpha.

Authors:  Osman Elbek; Meral Uyar; Neriman Aydin; Sermin Börekçi; Nazan Bayram; Hasan Bayram; Oner Dikensoy
Journal:  Clin Rheumatol       Date:  2008-12-04       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.